논문상세정보

' Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden' 의 참고문헌

  • Trail Making Test A and B: normative data stratified by age and education
    Tombaugh TN [2004]
  • Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data
    Smith SM [2006]
  • The cognitive profiles of CADASIL and sporadic small vessel disease
    Charlton RA [2006]
  • The Concept Shifting Test: adult normative data
  • Serum neurofilament light is sensitive to active cerebral small vessel disease
  • Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
    Rohrer JD [2016]
  • Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
    Disanto G [2016]
  • Serum neurofilament light chain levels are associated with clinical characteristics and outcome in patients with cervical artery dissection
    Traenka C [2015]
  • Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
    Kuhle J [2016]
  • Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease
    De Guio F [2016]
  • ROCR: visualizing classifier performance in R
    Sing T [2005]
  • Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials
    Benjamin P [2016]
  • Probabilistic diffusion tractography with multiple fibre orientations: what can we gain?
    Behrens TE [2007]
  • Plasma biomarkers of inflammation, endothelial function and hemostasis in cerebral small vessel disease
    Wiseman SJ [2015]
  • Ordinal: regression models for ordinal data
  • Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
    Wardlaw JM [2013]
  • Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis
    Lu CH [2015]
  • N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease
  • Monoclonal antibodies selective for low molecular weight neurofilaments
    Norgren N [2002]
  • Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study
    Markus HS [2005]
  • Increased neurofilament light chain blood levels in neurodegenerative neurological diseases
    Gaiottino J [2013]
  • Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease
    Duering M [2013]
  • Head motion parameters in fMRI differ between patients with mild cognitive impairment and Alzheimer disease versus elderly control subjects
    Haller S [2014]
  • Glmnetcr: fit a penalized constrained continuation ratio model for predicting an ordinal response
  • Generalized linear model diagnostics using the deviance and single case deletions
    Williams DA [1987]
  • Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial
    Pearce LA [2014]
  • Education modifies the relation of vascular pathology to cognitive function: cognitive reserve in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
    Zieren N [2013]
  • Diffusion tensor imaging and gait in elderly persons with cerebral small vessel disease
    de Laat KF [2011]
  • Cortical superficial siderosis in different types of cerebral small vessel disease
  • Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
    Kuhle J [2016]
  • Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study
  • Characterization and propagation of uncertainty in diffusion-weighted MR imaging
    Behrens TE [2003]
  • Cerebrospinal fluid biomarkers of white matter lesions: cross-sectional results from the LADIS study
    Jonsson M [2010]
  • Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
    Pantoni L [2010]
  • Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol
  • C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study
    Schmidt R [2006]
  • C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study
    van Dijk EJ [2005]
  • Association of prothrombotic status with markers of cerebral small vessel disease in elderly hypertensive patients
    Nagai M [2012]
  • Association of plasma neurofilament light with neurodegeneration in patients with alzheimer disease
    Mattsson N [2017]
  • Assessment scales in stroke: clinimetric and clinical considerations
    Harrison JK [2013]
  • Assessment of information processing in working memory in applied settings: the paper and pencil memory scanning test
  • Age-related decline in white matter tract integrity and cognitive performance: a DTI tractography and structural equation modeling study
  • A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms
    Baykara E [2016]
  • A comparative study of CSF neurofilament light and heavy chain protein in MS
    Kuhle J [2013]
  • A Language and Environment for Statistical Computing